Available studies (114 found)

Filter citations (author, year, title, ID)
Data type for full-text extraction
Short citationFull citationBioassayEpidemiologyEpi. meta-analysisIn vitroEcology
McDiarmid, 2010 McDiarmid MA, Oliver MS, Roth TS, Rogers B, and Escalante C. 2010. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 52(10): 1028-1034. PubMed DOI
McDiarmid, 2014 McDiarmid MA, Rogers B, and Oliver MS. 2014. Chromosomal effects of non-alkylating drug exposure in oncology personnel. Environmental and molecular mutagenesis 55(4): 369-374. PubMed DOI
McDonald, 1988a McDonald AD et al. Congenital defects and work in pregnancy. Br J Ind Med 1988; 45 (9):581-8. PubMed
McDonald, 1988b McDonald AD et al. Fetal death and work in pregnancy. Br J Ind Med 1988; 45 (3):148-57. PubMed
Medkova, 1990 Medkova J. 1990. Cytogenetic analysis of peripheral lymphocytes in occupationally exposed health personnel. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 126: 93-106. PubMed
Medkova, 1991 Medkova J. 1991. An analysis of the health condition of personnel exposed to cytostatics at an oncology unit. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 130: 311-322. PubMed
Milkovic-Kraus, 1991 Milkovic-Kraus S, and Horvat D. 1991. Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs. American journal of industrial medicine 19(6): 771-774. PubMed
Moretti, 2013 Moretti M, Villarini M, Dominici L, Fatigoni C, Dell'omo M, Elisei E, Muzi G, and Monarca S. 2013. [Evaluation of genotoxic effects in subjects occupationally exposed to antineoplastic drugs]. Igiene e sanita pubblica 69(1): 55-77. PubMed
Moretti, 2015 Moretti M et al. Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach. Int Arch Occup Environ Health 2015; 88 (6):683-95. PubMed DOI
Mrdanovic, 2012 Mrdanovic J, Jungic S, Solajic S, Bogdanovic V, and Jurisic V. 2012. Effects of orally administered antioxidants on micronuclei and sister chromatid exchange frequency in workers professionally exposed to antineoplastic agents. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 50(8): 2937-2944. PubMed DOI
Musak, 2006 Musak L, Vodicka P, Klimentova G, Soucek P, Hanova M, Mikulkova R, Buchancova J, Vodickova L, Polakova V, and Pec M. 2006. Chromosomal damage and polymorphisms of DNA repair genes XRCC1 and XRCC3 in workers exposed to cytostatics. Neuro endocrinology letters 27 Suppl 2: 57-60. PubMed
Musak, 2013 Musak L et al. Chromosomal damage among medical staff occupationally exposed to volatile anesthetics, antineoplastic drugs, and formaldehyde. Scand J Work Environ Health 2013; 39 (6):618-30. PubMed DOI
Nikula, 1984 Nikula E, Kiviniitty K, Leisti J, and Taskinen PJ. 1984. Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scandinavian journal of work, environment & health 10(2): 71-74. PubMed
Peelen 1999 Peelen S, Roeleveld N, Heederik D, Kromhout H, De Kort W (The Hague). 1999. Reproductietoxische effecten bij ziekenhuispersoneel [Toxic effects on reproduction in hospital personnel]. Netherlands: Employment DMoSAa.
Pilger, 2000 Pilger A, Kohler I, Stettner H, Mader RM, Rizovski B, Terkola R, Diem E, Franz-Hainzl E, Konnaris C, Valic E, and Rudiger HW. 2000. Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs. International archives of occupational and environmental health 73(7): 442-448. PubMed
Pohlova, 1986 Pohlova H, Cerna M, and Rossner P. 1986. Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs. Mutation research 174(3): 213-217. PubMed
Quansah, 2010 Quansah R and Jaakkola JJ. Occupational exposures and adverse pregnancy outcomes among nurses: a systematic review and meta-analysis. J Womens Health (Larchmt) 2010; 19 (10):1851-62. PubMed DOI
Ratner, 2010 Ratner PA, Spinelli JJ, Beking K, Lorenzi M, Chow Y, Teschke K, Le ND, Gallagher RP, and Dimich-Ward H. 2010. Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs. BMC nursing 9: 15. PubMed DOI
Rekhadevi, 2007 Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF, and Grover P. 2007. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Mutagenesis 22(6): 395-401. PubMed
Rodríguez-Montero, 2016 Rodríguez-Montero HM, Argote-Pelegrino E, Díaz-Curbelo A, Cuétara-Lugo EB. 2016. Genotoxicity biomarkers for monitoring occupational exposure to antineoplastic drugs. Journal of Pharmacy and Pharmacognosy Research 4(3): 122-133.
Rogers, 1987 Rogers B, and Emmett EA. 1987. Handling antineoplastic agents: urine mutagenicity in nurses. Image--the journal of nursing scholarship 19(3): 108-113. PubMed
Rombaldi, 2009 Rombaldi F, Cassini C, Salvador M, Saffi J, and Erdtmann B. 2009. Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week. Mutagenesis 24(2): 143-148. PubMed DOI
Roth, 1994 Roth S, Norppa H, Jarventaus H, Kyyronen P, Ahonen M, Lehtomaki J, Sainio H, and Sorsa M. 1994. Analysis of chromosomal aberrations, sister-chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs. Mutation research 325(4): 157-162. PubMed
Rubes, 1998 Rubes J, Kucharova S, Vozdova M, Musilova P, and Zudova Z. 1998. Cytogenetic analysis of peripheral lymphocytes in medical personnel by means of FISH. Mutation research 412(3): 293-298. PubMed
Sasaki, 2008 Sasaki M, Dakeishi M, Hoshi S, Ishii N, and Murata K. 2008. Assessment of DNA damage in Japanese nurses handling antineoplastic drugs by the comet assay. Journal of occupational health 50(1): 7-12. PubMed

Showing studies 51-75 of 114